GeneDx Holdings Corp.

WGS Nasdaq CIK: 0001818331

Company Information

Industry Services-Health Services
SIC Code 8000
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 333 LUDLOW STREET, STAMFORD, CT, 06902
Mailing Address 333 LUDLOW STREET, STAMFORD, CT, 06902
Phone 888-729-1206
Fiscal Year End 1231
EIN 851966622

Financial Overview

FY2025

$-0.73
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 30, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 11, 2026 View on SEC
4 Insider stock transaction report March 11, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC

Annual Reports

10-K February 23, 2026
  • Total revenue climbed to $300 million, a healthy 5.3% increase from $285 million in 2024, primarily driven by core diagnostic testing services.
  • GeneDx significantly expanded its capabilities by acquiring Fabric Genomics Inc. in May 2025, enhancing its genomic analysis platform with advanced AI and software solutions.
View Analysis

Insider Trading

STRONG BUY 4 insiders 75 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8000)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.